Background-In patients with left ventricular infarction or dilatation, leaflet tethering by displaced papillary muscles frequently induces mitral regurgitation, which doubles mortality. Little is known about the biological potential of the mitral valve (MV) to compensate for ventricular remodeling. We tested the hypothesis that MV leaflet surface area increases over time with mechanical stretch created by papillary muscle displacement through cell activation, not passive stretching. Methods and Results-Under cardiopulmonary bypass, the papillary muscle tips in 6 adult sheep were retracted apically short of producing mitral regurgitation to replicate tethering without confounding myocardial infarction or turbulence. Diastolic leaflet area was quantified by 3-dimensional echocardiography over 61Ϯ6 days compared with 6 unstretched sheep MVs. Total diastolic leaflet area increased by 2.4Ϯ1.3 cm 2 (17Ϯ10%) from 14.3Ϯ1.9 to 16.7Ϯ1.9 cm 2 (Pϭ0.006) with stretch with no change in the unstretched valves despite sham open heart surgery. Stretched MVs were 2.8 times thicker than normal (1.18Ϯ0.14 versus 0.42Ϯ0.14 mm; PϽ0.0001) at 60 days with an increased spongiosa layer. Endothelial cells (CD31 ϩ ) coexpressing ␣-smooth muscle actin were significantly more common by fluorescent cell sorting in tethered versus normal leaflets (41Ϯ19% versus 9Ϯ5%; Pϭ0.02), indicating endothelial-mesenchymal transdifferentiation. ␣-Smooth muscle actin-positive cells appeared in the atrial endothelium, penetrating into the interstitium, with increased collagen deposition. Thickened chordae showed endothelial and subendothelial ␣-smooth muscle actin. Endothelial-mesenchymal transdifferentiation capacity also was demonstrated in cultured MV endothelial cells. Conclusions-Mechanical stresses imposed by papillary muscle tethering increase MV leaflet area and thickness, with cellular changes suggesting reactivated embryonic developmental pathways. Understanding such actively adaptive mechanisms can potentially provide therapeutic opportunities to augment MV area and reduce ischemic mitral regurgitation. (Circulation. 2009;120:334-342.)
creased cardiac complications. [15] [16] [17] It is reasonable to suppose that an increase in MV leaflet surface area might compensate for ventricular remodeling and that the stressed MV, like other biological structures, might adapt by enlargement. However, little is known about MV tissue biology and potential for adaptation. Decreased leaflet distensibility has been reported in severe heart failure patients 18, 19 but not correlated with total leaflet area. MV leaflets acutely and reversibly elongate up to 15% under physiological tension, 20, 21 and recent work in 80 patients has shown that MV leaflet surface area measured by 3-dimensional echocardiography is greater by an average of 35% in patients with chronically tethered leaflets compared with normal control subjects. 22 Leaflet area, however, failed to increase in proportion to the geometric demands (3-dimensional tenting) imposed by PM displacement in patients with ischemic MR, in contrast to those with LV remodeling and no MR. Larger leaflets may therefore partially compensate for tethering. Current data, however, provide no proof that leaflet area actually increases over time within a given patient. It is also unknown whether the leaflets enlarge because of passive stretching or active remodeling and growth with increased cell content and matrix production. Leaflet elongation has recently been reported in a heart failure model in systole, when passive stretch may be superimposed on actual tissue growth. 23 The ability to study leaflet adaptation to stretch in standard ischemic MR models may also be confounded by several factors, including myocardial ischemia and infarction, which may cause fibrosis by secretion of signals such as transforming growth factor-␤ superfamily members (TGF-␤) 24 and periostin. 25 Turbulent MR flow itself appears to induce localized secondary lesions 26 ; isolated MR increases matrix turnover 27 ; and cardiac medications affect vascular response to growth factors. 28 To observe leaflet adaptation to tethering over time, we assembled a team to study MV cell biology and molecular pathways and designed a large-animal model that allows independent and controlled leaflet tethering without confounding ischemia or turbulent MR flow. Three-dimensional echocardiography allows leaflet area quantification at different times in the same heart. Using these resources, we tested the hypothesis that MV surface area increases over time with mechanical stretch and as a consequence of cell activation and matrix production as opposed to passive stretching. 
Methods

Animal Care
Twelve adult Dorsett hybrid sheep (weight Ͼ45 kg) were loaded for 3 days with amiodarone (200 mg/d orally) and then anesthetized (thiopentothal sodium 12.5 mL/kg IV), intubated, and ventilated at 15 mL/kg with 2% isoflurane-oxygen adjusted by blood-oxygen and CO 2 monitoring. Animals prophylactically received glycopyrrolate (0.4 mg IV), cephazolin (0.5 g IV), and amiodarone (150 mg IV drip) during surgery and intravenous lactated Ringer solution as needed.
Experimental Model
On the basis of Dr Carpentier's suggestion, PM retraction and leaflet tethering were achieved with a technique developed by the authors (J.L.G., J.D.B.) to overcome the challenge of tethering leaflets in a controlled fashion without producing MR or leaflet tissue disruption. After sterile left thoracotomy and pericardial cradle construction, under cardiopulmonary bypass, suture loops were inserted into the exposed PM tips (both medial PM heads), buttressed by Teflon felt pledgets, and exteriorized to the epicardium overlying the apical insertion of the PMs. These sutures then paralleled the PM axis, and retracting them pulled the PM tip and leaflets toward the apex ( Figure 1C and 1D) .
After the heart was restarted, suture length was adjusted just short of producing MR under echocardiography guidance, and the sutures were fixed to an anchoring Dacron patch attached to the apical epicardium to spread out local myocardial pressure over a larger area and avoid underlying ischemia. MV leaflets were tethered in 6 sheep cared for over 61Ϯ6 days, followed by left thoracotomy for high-quality imaging and 3-dimensional reconstruction of MV surface area after the 2 months of mechanical tethering. After 60 days, the heart was sterilely harvested.
Sheep with tethered MV leaflets (nϭ6) were compared with a group of 6 sheep with normal, unstretched MVs. Three of these sheep had bypass surgery and no leaflet tethering and were followed up over the same 2-month time. These studies conform to National Institutions of Heath guidelines for animal care and received Institutional Animal Care Committee approval.
Echocardiography
Doppler echocardiography data were collected epicardially with a high-frequency (3.5-to 5-MHz) transthoracic echocardiography probe. Two-and 3-dimensional echocardiography probes (S5, X3) interfaced with a Philips iE33 scanner (Andover, Mass). Threedimensional volumetric data sets were ECG gated from 4 to 7 consecutive heartbeats. Full data sets were acquired in standardized planes at baseline and before 60 days. MR presence or absence and grade based on long-axis-view vena contracta 29 and successful MV leaflet tethering were immediately assessed. Data were digitally Total MV leaflet area can be measured precisely only in diastole because in systole the area of each leaflet involved in coaptation cannot be optimally resolved. Measuring diastolic leaflet area also evaluates adaptation when LV pressure and leaflet tension are minimal without passive systolic stretch. 13 Therefore, total leaflet area in full diastolic opening was analyzed with Omni4D, as validated against excised MV specimens in 15 sheep 22 with excellent correlation and agreement (R 2 ϭ0.86; SEEϭ1.24; mean differenceϭ0.51Ϯ1.15; Pϭ0.71). All offline echocardiography data were measured in a blinded fashion by a single observer.
MV Tissue Harvesting
Sheep hearts were harvested, the left atrium was opened, and the LV wall was dissected starting at the anterolateral commissure in a sterile manner under irrigation of precooled PBS. Anterior and posterior leaflets with chordae and PMs were dissected and divided for histopathology (frozen in optimal cutting temperature compound and stored at Ϫ80°C), cell isolation, and flow cytometry (transported fresh in cooled physiological collecting medium).
Histology
Overall MV morphology was analyzed with hematoxylin and eosin stain. MV and chordae collagen architecture was detected by Masson trichrome staining. Leaflet thickness was measured by microscopy in the 10 thickest areas across the midportion of the anterior and posterior leaflets and similarly explored for the leaflet bases and tips. Chordal length and thickness (anterior and posterior strut chordae) were measured on calibrated gross pathology photographs from the PM tip to furthest leaflet insertion (Adobe, San Jose, Calif); the thickness of 10 randomly selected chords was measured by microscopy. Endothelial cells (ECs) were identified with anti-CD31 antibody (Santa Cruz Biotechnology, Santa Cruz, Calif). The activated valvular interstitial cell phenotype was determined by immunohistochemistry for myofibroblast markers (anti-␣-smooth muscle actin [anti-␣-SMA]; clone 1A4; Sigma, St Louis, Mo). 30 -33 In addition, to show the clinical relevance of our model, we obtained excised MV leaflets from patients with ischemic MR (nϭ4).
MV Cell Analysis
The aim was to determine whether valve ECs expressing CD31 are altered in tethered leaflets and express the interstitial cell marker ␣-SMA. This would indicate that the valve endothelium is an adaptive reservoir for adding interstitial cells through endothelialmesenchymal transdifferentiation (EMT).
Valve tissue was minced into 1ϫ1-mm pieces and digested with Cell Dissociation Buffer (Invitrogen, Carlsbad, Calif) for 4 minutes at 37°C at a specific ratio of tissue to volume to obtain a single-cell suspension of endothelial and interstitial cells and to quantify valvular cells transitioning to a mesenchymal phenotype by flow cytometry. ECs were detected and quantified with murine anti-sheep CD31 antibody conjugated to fluorescein isothyocyanate (AbD Serotec, Oxford, UK); activated cells were detected with a murine anti-human ␣-SMA (clone 1A4) conjugated to phycoerythrin (R&D Systems, Minneapolis, Minn). Anterior and posterior leaflets were analyzed separately.
Direct Demonstration of Capacity for EMT
Aortic and pulmonary valve ECs have been induced to undergo EMT in vitro, 30, 33, 34 but that has not been shown before for MV ECs. Therefore, as an ancillary study to test directly whether MV ECs are competent to undergo EMT, we isolated clonal MV EC populations; treated them with TGF-␤1, TGF-␤2, or TGF-␤3 (1 ng/mL for 5 days); and evaluated the onset of ␣-SMA expression, widely regarded as a marker for EMT, 35 by immunostaining and Western blot of cell lysates.
Sample Size and Power
We hypothesized that chronic tethering would result in a 25% increase in leaflet area, consistent with clinical and pilot data. To demonstrate such changes with 5% ␣ error and 80% power, a minimum of 5 animals per group was required.
Statistical Analysis
Data are summarized as meanϮSD for continuous variables. Paired Student t test compared baseline and final results within the same animal. Student t test was used to compare continuous variables between groups. Statistical significance was set at PϽ0.05.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results
The experimental model uniformly produced PM retraction and mildly tented mitral leaflets ( Figure 1D ) consistent with tethering, confirmed by increased tenting volume between annulus and leaflets (Table 1) . No animal had more than mild MR at baseline or follow-up studies, with no significant change in MR vena contracta from baseline (Table 1) .
Leaflet Anatomy
Total diastolic MV leaflet area consistently increased by an average of 2.4Ϯ1.3 cm 2 (17Ϯ10%) from 14.3Ϯ1.9 to 16.7Ϯ1.9 cm 2 (Pϭ0.006) with maintained stretch with no significant change in unstretched valves despite sham open heart surgery (14.5Ϯ1.2 to 14.7Ϯ2 cm 2 ; Pϭ0.9). Leaflet area did not increase more (8%) in the 1 sheep that developed mild MR (vena contractaϭ0.38 cm). Leaflet length also increased significantly over time in the stretched MVs (Table 1) . Gross pathology at 60 days showed increased leaflet size and opacity, consistent with increased thickness (Figure 2 ). By histology, stretched MVs were 2.8 times thicker than normal at their midportions (1.18Ϯ0.14 versus 0.42Ϯ0.14 mm; PϽ0.0001) with an increased spongiosa layer (Figure 3 ). Leaflet thickness also increased Ͼ60% in both the leaflet body and distal tip in sham versus stretched MVs (Table 2) . Diastolic annular area increased by an average of 15% with no change in the ratio of leaflet to annular area (1.73Ϯ0.17 versus 1.74Ϯ0.15; Pϭ0.9), a ratio that is likewise comparable in patients with tethered versus normal leaflets. 22 
Chordal Anatomy
Anterior and posterior chordae were significantly thicker ( Figures 2 and 4 , left) and longer in stretched versus unstretched MVs for both photographic measurements of the thicker strut chordae and averaged microscopic chordal thickness (Table 2) .
EMT in MV Leaflets
By flow cytometry, ECs (CD31 ϩ ) coexpressing ␣-SMA were significantly more common in tethered anterior and posterior leaflets versus untethered leaflets, comprising 41Ϯ19% versus 9Ϯ5% of all ECs (Pϭ0.02; Figure 5A and 5B).
Molecular Histopathology
Unstretched MV leaflets and chordae showed CD31 ϩ cells along the endothelial layer without ␣-SMA staining ( Figure  6 , left). In contrast, stretched leaflets consistently showed both CD31 and ␣-SMA staining in the endothelial layer, indicating activation/EMT, almost exclusively along the atrial border; individual ␣-SMA ϩ cells also appeared to penetrate 
Cell Activation and EMT in Human Ischemic MR
Immunohistochemistry of MV leaflets from all 4 patients with ischemic MR showed ␣-SMA expression in the endothelium and in valvular interstitial cells throughout the leaflets (Figure 8 ), suggesting that human diseased valves undergo EMT and valvular interstitial cell activation similar to those detected in the sheep model. Figure 5C and 5D show that beginning with an MV EC clone with documented endothelial phenotype (CD31 ϩ /␣-SMA Ϫ ), TGF-␤1, TGF-␤2, and TGF-␤3 all induced ␣-SMA expression. Therefore, similar to postnatal aortic and pulmonary valve ECs, 30, 33, 34 MV ECs can be induced to undergo EMT.
Capacity of MV ECs for EMT: Direct Demonstration
Discussion
This experimental study goes beyond prior clinical observations and proves that tethered MV leaflets increase in area within the same heart over time. Activation of cells and thickening of the interstitial matrix with an altered cell biology indicate EMT, which was detected by dual labeling for endothelial and interstitial cell markers in both leaflets and chordae.
Developmental Perspective
During embryonic cardiac valve development, factors such as TGF-␤, bone morphogenetic proteins, epidermal growth factor, and vascular endothelial growth factor, along with Notch, signal ECs overlying myocytes to lose cell-cell contacts, migrate into the cardiac jelly (primordial valve interstitium), reduce expression of endothelial markers, and gain mesenchymal markers such as ␣-SMA (Figure 6, bottom) . 36 -39 This EMT forms the endocardial cushions, the primordia of the cardiac valves and septa. 40 Post-EMT cushion valvular maturation seems to be regulated by the same signals and fibroblast growth factor. 41 Subsequent leaflet delamination from the ventricular wall relates in part to periostin, a protein secreted by fibroblasts.
After embryonic development and throughout adult life, human valves maintain cell plasticity (quiescent fibroblastsϾactivated myofibroblasts detected by ␣-SMA) and dynamic structure (nascent extracellular matrix) to respond to hemodynamic changes. In this study, the high prevalence of ␣-SMA-positive cells and their interstitial penetration in stretched valves suggest reactivated embryonic valve developmental pathways/EMT and support the concept of an actively adapting MV. 42 This process appears to begin on the atrial layer (Figures 6 through 8) . A possible explanation is that this layer, with its higher radius of curvature, bears high mechanical stresses by the Laplace law 43 ; alternatively, the atrial and ventricular endothelia may have biological differences. 44 
Clinical Observations
This study is based entirely on an animal model. However, to begin exploring whether the findings have a clinical counterpart, particularly in more chronic tethering, we examined human MVs affected by ischemic MR (nϭ4), all of which had ␣-SMA-positive cell activation and distribution similar to that in the animal model (Figure 8 ), apparently as an ongoing process despite advanced age (71Ϯ2.6 years) and disease chronicity.
Mechanism and Therapeutic Implications
Increased leaflet length and interstitial thickness have been observed in a Marfan syndrome mouse model, 45 correlated with TGF-␤ activation. Mechanical stresses caused by PM tethering may upregulate TGF-␤, 46 which, as we have shown, induces EMT in MV ECs; increased TGF-␤ could similarly explain the increased leaflet length and interstitial thickness in our model. Ischemic myocardium also may stimulate MV leaflet growth and collagen production 47 by secreting TGF-␤, which is elevated in both infarcted and remote noninfarcted myocardium. 48 The turbulent MR jet may further signal the MV leaflets to change, as suggested by Dr Carpentier on the basis of localized thickening of otherwise thin MVs in regions of chordal rupture. 26 The ischemic and volumeoverload lesions, 27 however, may have other local and paracrine effects on valve growth that may help explain the frequent insufficiency of leaflet adaptation to prevent MR. 22 Understanding the mechanisms of MV adaptation has potential therapeutic implications, with the long-range goal of augmenting the MV area to reduce ischemic MR. There is growing recognition that the TGF-␤ pathways influencing valve growth are susceptible to pharmacological modification. For example, using an angiotensin receptor blocker as a TGF-␤ antagonist has been shown to limit tissue growth in a Marfan mouse model 28 and is now undergoing clinical trials. Converse approaches might augment the adaptive process in remodeled LVs while preserving physiological leaflet biomechanics. 49 Surgical strategies may also incorporate leaflet augmentation to improve repair efficacy.
Models, Limitations, and Future Directions
These results are consistent with those of Timek et al 23 in a sheep pacing-induced cardiomyopathy model using radiopaque markers along the leaflet midline. Systolic leaflet length increased over 15 days, although the tethering distance from the PMs to the annulus did not appear to increase, in contrast to the inferior myocardial infarction situation. 6,7 Diastolic leaflet area was measured in the present study to separate the effects of valve adaptation; systolic area might be different in hearts with stretched versus unstretched valves because of both valve growth and passive systolic stretch. In addition, in systole, the juxtaposed coapted leaflet areas cannot be optimally resolved.
Although isolated mechanical stretch is only 1 element of the ischemic MR substrate, the leaflet stretch model allows isolation of mechanical, ischemic, and MR flow components to test their influence on valve growth alone and in combination. The purpose of this study, however, was specifically to focus on the influence of leaflet stretch. This model also provides a platform for subsequently studying controlled changes in other factors.
The model allows standardization of the PM stretch to produce leaflet tenting but with no more than mild MR ( Figure 1D) . Direct staining and quantitative analysis of TGF-␤ and related signaling pathways are being done in follow-up studies. Adequacy of chordal changes and the nature and role of annular enlargement, not areas of initial focus, also warrant further investigation, including precise delineation of chordal length and insertion. The role of intrinsic and hematopoietic-derived progenitor cells in leaflet adaptation 34, 50 also requires additional analytic approaches.
Conclusions
Mechanical stresses imposed by PM tethering increase MV leaflet area and matrix thickness, with cellular changes suggestive of reactivated embryonic valve development pathways. These findings support the concept of an actively adapting MV; understanding adaptive mechanisms can potentially provide therapeutic opportunities to augment MV area and reduce ischemic MR.
CLINICAL PERSPECTIVE
Mitral regurgitation is a frequent complication of myocardial infarction that doubles heart failure and mortality and is caused by stretch of the mitral leaflets by damaged and bulging heart walls preventing effective valve closure. Compensatory valve growth could reduce mitral regurgitation. A recent patient study showed significantly enlarged leaflets in patients with left ventricular dysfunction compared with normal subjects; whether the valve actively grows over time or is just passively stretched is unknown. The individual effects of ischemia, regurgitant jet flow, and leaflet stretch on potential valve adaptation, all present in ischemic MR, also are unknown. This study combined a new model producing isolated and controlled leaflet stretch with a noninvasive technique for quantifying valve area changes over time in an interdisciplinary collaboration with basic scientists. Two months of leaflet stretch by apical papillary muscle retraction reactivated embryonic development pathways, resulting in valvular and chordal growth shown by cellular activation, transformation of endothelial to interstitial cells, and new matrix deposition. Leaflet surface area and both leaflet and chordal thickness increased substantially relative to baseline and unstretched controls. The mitral valve therefore actively adapts in this setting. Understanding the mechanisms of such active adaptation can potentially provide therapeutic opportunities to augment MV area and reduce ischemic MR.
